Cleared Traditional

K121073 - POWERGLIDE MIDLINE CATHETER

K121073 is an FDA 510(k) clearance for POWERGLIDE MIDLINE CATHETER, manufactured by C.R. Bard, Inc.. The device is a Class 2 General Hospital device with product code FOZ cleared through the Traditional 510(k) pathway after a 53-day FDA review.

K121073 · C.R. Bard, Inc. · General Hospital
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2012
Decision
53d
Days
Class 2
Risk

K121073 is an FDA 510(k) clearance for the POWERGLIDE MIDLINE CATHETER. Classified as Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (product code FOZ), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Salt Lake Ciy,, US). The FDA issued a Cleared decision on June 1, 2012 after a review of 53 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5200 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K121073

510(k) Number K121073 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 09, 2012
Decision Date June 01, 2012
Days to Decision 53 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 129d · This submission: 53d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FOZ Device Classification - Class 2, Special Controls

Product Code FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 492
Devices cleared under the same product code (FOZ) and FDA review panel - the closest regulatory comparables to K121073.
TERUMO SURFLASH SAFETY I.V. CATHETER
K122544 · Terumo Corporation · Sep 2012
NOVACATH SECURE IV CATHETER SYSTEM-18G
K120839 · Tangent Medical Technologies, Inc. · Jul 2012
M/29TM - PRESSURE INJECTABLE
K111939 · Flexicath , Ltd. · Jul 2012
MULTI-MED CENTRAL VENOUS CATHETERS (CVCS), WITH AND WITHOUT HEPARIN VANTEX CENTRAL VENOUS CATHETERS (CVCS), WITH HEPARIN
K113565 · Edwards Lifesciences, LLC · May 2012
ORION II CT CVC
K113622 · Health Line International Corporation (Hlic) · May 2012
SUPERCATH Z3V
K112290 · Togo Medikit Co., Ltd. · Apr 2012
K121073 · POWERGLIDE MIDLINE CATHETER
Download PDF FDA Summary C.R. Bard, Inc.